ALLERGAN PLC (AbbVie Inc.)

Company Overview

Allergan PLC is headquartered in Ireland and was incorporated as public limited company in September 2013. The company, formerly Actavis PLC, was established to facilitate the business between Warner Chilcott PLC and Actavis Inc. The company manufactures, develops, markets and distributes pharmaceutical products, medical aesthetics, biosimilars and OTC pharmaceutical products. The company’s acquisition of Allergan in March 2015 extended its reach into the ophthalmology, neurosciences, medical aesthetics and plastic surgery spaces. The company operates in over 100 countries, including the U.S., Canada, Europe, Southeast Asia and other high-value growth markets, such as China, India, the Middle East and Latin America.

Allergan operates and manages business in three distinct operating divisions: U.S. Specialized Therapeutics, U.S. General Medicine and International. The operating segments are organized as follows:

• The U.S. Specialized Therapeutics segment includes sales and expenses related to certain branded products within the U.S., including medical aesthetics, medical dermatology, eye care, neurosciences and urology therapeutic products.

• The U.S. General Medicine segment includes sales and expenses related to branded products within the U.S. that do not fall into the U.S. Specialized Therapeutics business units, including central nervous system, gastrointestinal, women’s health, anti-infectives and diversified Brands.

• The International segment includes sales and expenses relating to products sold outside the U.S.

Company's Business Segments

• Pharmaceutical Products and Solutions : This segment focuses on four key therapeutic areas: medical aesthetics, central nervous system, eye care, and gastroenterology.